-
Product Insights
Aspergillosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Aspergillosis - Drugs In Development, 2023’, provides an overview of the Aspergillosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aspergillosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – olorofim
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry olorofim Drug Details F-901318 is under development for the treatment of invasive fungal infections,...
-
Product Insights
Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Aspergillosis is an infection or allergic response due to the Aspergillus fungus. The Aspergillosis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Aspergillosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report reviews key...
-
Product Insights
Coccidioidomycosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache, fatigue, and joint aches. Risk factors include the weakened immune system, age, pregnancy, race, and environmental exposure. Treatment includes antifungal medications. The Coccidioidomycosis drugs in development market research report provide comprehensive information on the therapeutics under development for Coccidioidomycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....
-
Product Insights
Fungal Infections – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides a comprehensive overview of the fungal infections clinical trials landscape. It provides top-line data relating to the clinical trials on fungal infections including an overview of trials count and their average enrollment in top countries conducted globally. The report also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based...
-
Product Insights
Aspergillosis Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Aspergillosis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Aspergillosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Aspergillosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Fungal Infections Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Fungal Infections Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Fungal Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Fungal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Mycoses Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycoses Global Clinical Trials Review, H1, 2018" provides an overview of Mycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Mycoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Aspergillosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2018" provides an overview of Aspergillosis clinical trials scenario. This report provides top line data relating to the clinical trials on Aspergillosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...